China approves clinical trials of Sinopharm's Omicron-specific jab

Name: China approves clinical trials of Sinopharm's Omicron-specific jab
Uploaded: 2022-04-28T02:20:35+03:00
Description: China approves clinical trials of Sinopharm's Omicron-specific jab

Published 28 April 2022